HomepageMedicineGSK Completes Acquisition of Aiolos Bio Medicine GSK Completes Acquisition of Aiolos Bio admin Posted on February 16, 2024 This acquisition will add asthma treatment A1O-001 to GSK’s portfolio. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostIFSCA Chairman promises clarity on family office structures for resident HNIs in 2-3 months Next PostA.I. Art That’s More Than a Gimmick? Meet AARON You Might Also Like Medicine Regeneron Global Program Head of Linvosoltamab Discusses the Potential for Linvosoltamab to Become a Frontline Treatment for Multiple Myeloma admin June 2, 2024 Medicine Study Suggests Promise of Psilocybin in Treating Depressive Symptoms admin August 23, 2024 Medicine Recent Developments in Pharmaceutical Validation admin November 4, 2024 Medicine US Pharma and Biotech Summit 2024: The View from Investors admin May 17, 2024
Medicine Regeneron Global Program Head of Linvosoltamab Discusses the Potential for Linvosoltamab to Become a Frontline Treatment for Multiple Myeloma admin June 2, 2024